These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
o
|
Preliminary Proxy Statement
|
|
|
o
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
|
x
|
Definitive Proxy Statement
|
|
|
o
|
Definitive Additional Materials
|
|
|
o
|
Soliciting Material Under Rule 14a-12
|
|
x
|
No fee required.
|
||
|
o
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
|
||
|
1)
|
Title of each class of securities to which transaction applies:
|
||
|
2)
|
Aggregate number of securities to which transaction applies:
|
||
|
3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined):
|
||
|
4)
|
Proposed maximum aggregate value of transaction:
|
||
|
5)
|
Total fee paid:
|
||
|
o
|
Fee paid previously with preliminary materials.
|
||
|
o
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing:
|
||
|
1)
|
Amount previously paid:
|
||
|
2)
|
Form, Schedule or Registration Statement No:
|
||
|
3)
|
Filing Party:
|
||
|
4)
|
Date Filed:
|
||
|
|
1.
|
Elect two directors, each for a term of three years;
|
|
|
2.
|
Ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for fiscal year 2016; and
|
|
|
3.
|
Transact any other business that may properly come before the meeting or any postponements or adjournments of the meeting.
|
|
|
·
|
the election of the two nominees to the Board of Directors;
|
|
|
·
|
the ratification of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm.
|
|
By order of the Board of Directors,
Isaac Angel
Chief Executive Officer
|
|
|
1.
|
Elect the two directors named in the attached Proxy Statement, each for a term of three years;
|
|
|
2.
|
Ratify the appointment of PricewaterhouseCoopers LLP as Ormat Technologies, Inc.’s independent registered public accounting firm for the year ending December 31, 2016; and
|
|
|
3.
|
Transact any other business that may properly come before the meeting or any postponements or adjournments of the meeting.
|
|
|
·
|
This Proxy Statement, the proxy card form, the Notice of Internet Availability of Proxy Materials and our Annual Report on Form 10-K are available at
http://materials.proxyvote.com/686688
by clicking on the proxy link.
|
|
|
·
|
You will need your assigned control number to vote your shares. Your control number can be found on your proxy card or voting instruction form.
|
|
|
·
|
The time and location of the Annual Meeting of Stockholders are noted above.
|
|
By order of the Board of Directors,
/s/ Isaac Angel
Isaac Angel
Chief Executive Officer
|
|
1
|
|
|
Questions and Answers about the 2016 Annual Meeting of Stockholders
|
2
|
|
5
|
|
|
Our Current Nominees
|
5
|
|
Our Continuing Directors
|
7
|
|
9
|
|
|
Board Leadership Structure
|
9
|
|
Board Committees
|
9
|
|
Majority Voting for Directors
|
12
|
|
Compensation Committee Interlocks and Insider Participation
|
12
|
|
Code of Business Conduct and Ethics
|
13
|
|
Corporate Governance Guidelines
|
13
|
|
Executive Sessions
|
13
|
|
Stockholder Communications with the Board of Directors
|
13
|
|
Board's Role in Risk Oversight
|
13
|
|
14
|
|
|
16
|
|
|
18
|
|
|
22
|
|
|
25
|
|
|
26
|
|
|
Summary Compensation Table
|
26
|
|
Grants of Plan-Based Awards
|
28
|
|
Employment Agreements
|
28
|
|
Outstanding Equity Awards at Fiscal Year-End
|
29
|
|
Option Exercises
|
30
|
|
Potential Payments upon Termination or Change in Control
|
30
|
|
Estimated Payments and Benefits upon Termination
|
32
|
|
33
|
|
|
34
|
|
| 36 | |
| 37 | |
| 39 |
|
Appointment of Registered Public Accounting Firm
|
39
|
|
Audit and Non-Audit Fees
|
42
|
|
Audit Committee Pre-Approval Procedures for Independent Registered Public Accounting Firm
|
39
|
|
41
|
|
|
41
|
|
|
Householding of Proxies
|
41
|
|
Additional Filings
|
41
|
|
Proxy Solicitation
|
41
|
|
Section 16(a) Beneficial Ownership Reporting Compliance
|
42
|
|
Stockholder Proposals for 2017 Annual Meeting of Stockholders
|
42
|
|
|
·
|
vote by internet or by telephone and how you can receive a paper or email copy of a proxy card if you are a record holder of shares; or
|
|
|
·
|
give voting instructions to your bank or brokerage firm if your shares are held in street name.
|
|
|
● by signing and delivering another proxy with a later date;
|
|
|
● by giving written notice of such revocation to the Corporate Secretary of Ormat prior to or at the meeting; or
|
|
|
● by voting in person at the meeting.
|
|
●
|
The election of the two nominees named in this proxy statement to the Board; and
|
|
|
● The ratification of PricewaterhouseCoopers LLP as Ormat’s independent registered public accounting firm for the year ending December 31, 2016.
|
|
|
Stanley B. Stern*
|
|
|
David Granot*
|
|
|
Robert E. Joyal*
|
|
|
Ravit Barniv*
|
|
|
Robert F. Clarke*
Ami Boehm*
|
|
|
Gillon Beck*
|
|
|
Dan Falk*
|
|
|
·
|
Dan Falk.
Dan Falk has been a member of our Board since November 12, 2004. Mr. Falk also serves as the Chairman of the Board of Directors of AVT - Advanced Vision Technology (A.V.T.) Ltd., a public non-U.S. company. He is also a member of the Boards of Directors of Orbotech Ltd., Nice Systems Ltd. and Attunity Ltd., all NASDAQ publicly traded companies. During the past five years, Mr. Falk served as a member of the Boards of Directors of the following public companies, for which he no longer serves as a Director: Nova Measuring Systems Ltd., Amiad Water Systems Ltd., Plastopil Ltd. and Oridion Medical Ltd.
From 2001 to 2004, Mr. Falk was a business consultant to several public and private companies. From 1999 to 2000, Mr. Falk was Chief Operating Officer and Chief Executive Officer of Sapiens International N.V. From 1995 to 1999, Mr. Falk was an Executive Vice President of Orbotech Ltd. From 1985 to 1995, Mr. Falk was Vice President of Finance and Chief Financial Officer of Orbot Systems Ltd. and Orbotech Ltd. Mr. Falk obtained a Masters of Business Administration from Hebrew University in 1972 and a Bachelor of Arts in Economics and Political Science from Hebrew University in 1968. Mr. Falk is 72 years old.
The Board, following recommendation of our Nominating and Corporate Governance Committee, has concluded that Mr. Falk should serve as director of the Company primarily because of his qualification as an "audit committee financial expert" under Section 407 of the Sarbanes-Oxley Act of 2002 and Item 407(d)(5) of Regulation S-K, his experience related to service on the audit committee, his financial reporting expertise, and his general financial and business knowledge.
|
|
|
·
|
Gillon Beck
.
Gillon Beck has been the Chairman of our Board since November 17, 2015 and a member of our Board since May 22, 2012. He also served as Chairman of our Board from May 22, 2012 until June 30, 2014. Since 2003, Mr. Beck has been a Senior Partner at FIMI Opportunity Funds, as well as a Director of the FIMI Opportunity Funds' General Partners and SPV companies. In addition, Mr. Beck currently serves as Chairman of the Board of Directors of Ham-Let (Israel-Canada) Ltd. (traded on the Tel Aviv Stock Exchange (TASE)), Chairman of Magal Security Systems Ltd. (traded on NASDAQ) and Chairman of Inrom Industries, Ltd., Rivulis Ltd, H.R. Givon Ltd., Overseas Commerce Ltd and Oxygen and Argon Works Ltd, the five of which are private companies. He also serves as a member of the Board of Directors of Inrom Construction Material Ltd (traded on TASE). During the past five years, Mr. Beck had served as a member of the Board of Directors of the following public companies: Ormat Industries Ltd and Retalix Ltd. From 1999 to 2003, Mr. Beck served as Chief Executive Officer and President of Arad Ltd., a publicly-traded water measurement and automatic meter reading company, and from 1995 to 1999, he served as Chief Operating Officer of Arad Ltd. Mr. Beck received a Bachelor of Science degree (Cum Laude) in Industrial Engineering in 1990 from the Technion – Israel Institute of Technology, and a Master of Business Administration in Finance in 1992 from Bar-Ilan University. Mr. Beck is 54 years old.
The Board, following recommendation of our Nominating and Corporate Governance Committee, has concluded that Mr. Beck should serve as director of the Company primarily because of his extensive management experience and overall business and financial knowledge.
|
|
|
·
|
making recommendations to the Board as to changes in Ormat’s general compensation philosophy;
|
|
|
·
|
overseeing the development and implementation of compensation programs;
|
|
|
·
|
reviewing and approving corporate goals and objectives relevant to the compensation of the CEO, and evaluating the performance of the CEO in light of those goals and objectives; and
|
|
|
·
|
reviewing and approving the annual compensation of the CEO and Ormat’s five other most highly compensated executive officers who receive total compensation in excess of $1 million per year.
|
|
Dan Falk, Chair
Robert F. Clarke
David Granot
Robert E. Joyal
|
|
Name
|
Age
|
Position
|
||
|
Isaac Angel
|
59
|
Chief Executive Officer
|
||
|
Doron Blachar
|
48
|
Chief Financial Officer
*
|
||
|
Zvi Krieger
|
60
|
Executive Vice President—Electricity Segment
*
|
||
|
Bob Sullivan
|
53
|
Executive Vice President—Business Development Sales and Marketing
|
||
|
Shlomi Argas
|
51
|
Executive Vice President—Projects
*
|
||
|
Shimon Hatzir
|
54
|
Executive Vice President—Engineering
*
|
||
|
Erez Klein
|
50
|
Executive Vice President—Production
*
|
||
|
Nir Wolf
|
50
|
Executive Vice President—Market Development
*
|
||
|
Etty Rosner
|
60
|
Corporate Secretary; Senior Vice President—Contract Management
*
|
|
|
● each person, or group of affiliated persons, known to us to own beneficially 5% or more of our outstanding Common Stock;
|
|
|
● each of our directors;
|
|
|
● each of our Named Executive Officers (as defined under "Summary Compensation Table" below); and
|
|
|
● all of our directors and executive officers as a group.
|
|
Shares of
Common Stock
Beneficially Owned
|
||||||||
|
Number
|
Percent
|
|||||||
|
Principal Stockholder:
|
||||||||
|
FIMI ENRG, L.P. and FIMI ENRG, Limited Partnership
|
10,933,361 | (1) | 22.22 | % | ||||
|
Bronicki Investments Ltd.
|
10,933,361 | (1) | 22.22 | % | ||||
|
Migdal Insurance & Financial Holdings Ltd.
|
5,523,590 | (2) | 11.22 | % | ||||
|
Clal Insurance Enterprises Holdings Ltd.
|
2,649,285 | (3) | 5.38 | % | ||||
|
Psagot Investment House Ltd.
|
2,768,337 | (4) | 5.63 | % | ||||
|
Itshak Sharon (Tshuva) Delek Group Ltd & The Phoenix Holding ltd
|
2,840,139 | (7) | 5.77 | % | ||||
|
The Vanguard Group
|
2,546,779 | (8) | 5.18 | % | ||||
|
Directors and Named Executive Officers
|
||||||||
|
Gillon Beck
††
|
7,344,118 | (6),(9) | 14.86 | % | ||||
|
Dan Falk
††
|
22,500 | (10) | — | |||||
|
Ami Boehm
††
|
7,344,118 | (6)(11) | 14.86 | % | ||||
|
Robert F. Clarke
††
|
22,500 | (12) | — | |||||
|
Robert E. Joyal
††
|
15,000 | (13) | — | |||||
|
David Granot
††
|
15,000 | (14) | — | |||||
|
Ravit Barniv
|
7,500 | (20) | — | |||||
|
Stanley Stern
|
7,500 | (20) | — | |||||
|
Isaac Angel
|
75,000 | (21) | — | |||||
|
Doron Blachar
†
|
99,375 | (15) | — | |||||
|
Zvi Krieger
|
11,000 | (16) | — | |||||
|
Shimon Hatzir
|
23,000 | (17) | — | |||||
|
Nir Wolf
|
11,000 | (18) | — | |||||
|
Directors and Named Executive Officers as a group
|
11,302,736 | (19) | 22.97 | % | ||||
|
†
|
c/o Ormat Systems Ltd., Industrial Area, P.O. Box 68 Yavne 81100, Israel
|
|
††
|
c/o Ormat Technologies, Inc., 6225 Neil Road, Reno, Nevada 89511
|
|
*
|
Represents beneficial ownership of less than 1% of the outstanding shares of Common Stock.
|
|
(1)
|
The information provided for FIMI ENRG, L.P. ("FIMI ENRG 1") and FIMI ENRG, Limited Partnership ("FIMI ENRG 2", and together with FIMI ENRG 1, "FIMI") and Bronicki Investments Ltd. ("Bronicki Investments") is based on the Schedule 13D filed with the SEC on February 17, 2015 by FIMI and the Form 4 filed with the SEC on February 29, 2016 by Bronicki Investments. As reported therein, FIMI is the beneficial owner of 7,314,118 shares, representing beneficial ownership of 14.86% of our shares, and Bronicki Investments is the beneficial owner of 3,619,243 shares, representing beneficial ownership of 7.35% of our shares. FIMI and Bronicki Investments are party to (i) a shareholder rights agreement dated March 16, 2012and amended and restated on November 10, 2014, and (ii) a share purchase agreement dated March 16, 2012. By virtue of the shareholder rights agreement, each of FIMI and Bronicki Investments may be deemed to beneficially own, and have shared voting power over, the shares of our Common Stock beneficially owned by the other party such that, collectively, they may be deemed to beneficially own 10,933,361 shares or 22.22% of our shares. Each of FIMI and Bronicki Investments disclaims beneficial ownership of all shares of our Common Stock beneficially owned by the other party. FIMI's address is 98 Yigal Alon Street, Tel- Aviv, Israel 67891. Bronicki Investments' address is 5H’ Brosh 5 Street, Yavne, Israel 81510. See also footnotes 3 and 4 below.
|
|
(2)
|
The information provided for
Migdal Insurance & Financial Holdings Ltd
. ("Migdal") is based on Migdal's Schedule 13G filed with the SEC on February 10, 2016. Migdal reported shared voting and dispositive power with regard to all of the
5,523,590
shares beneficially held by Migdal and that of the 5,523,590 shares reported
(i)
5,360,752
shares are held for members of the public through, among others, provident funds, mutual funds, pension funds and insurance policies, which are managed by subsidiaries of Migdal, according to the following segmentation:
2,933,296
shares are held by profit participating life assurance accounts,
2,202,283
shares are held by provident funds and companies that manage provident funds and
225,173
shares are held by companies for the management of funds for joint investments in trusteeship, each of which subsidiaries operates under independent management and makes independent voting and investment decisions, and (ii)
162,838
are beneficially held for their own account (Nostro account).
Migdal disclaims beneficial ownership of 5,523,590 of these shares. Migdal's address is
4 Efal Street; P.O. Box 3063; Petach Tikva 49512, Israel
.
|
|
(3)
|
The information provided for Clal Insurance Enterprises Holdings Ltd. ("Clal") is based on Clal's Schedule 13G/A filed with the SEC on February 25, 2016. Clal reported shared voting and dispositive power with regard to all of the 2,649,285 shares beneficially held by Clal and that of the 2,649,285 (excluding 13,866 shares that are held for members of the public through, among others, portfolio management and/or mutual funds, which are managed by Epsilon Investment House Ltd., and/or Epsilon Mutual Management (1991) Ltd., each an indirect subsidiary of IDB Development Corporation Ltd. account. Clal's address is 48 Menachem Begin Road, Tel Aviv 66180, Israel.
|
|
(4)
|
The information provided for Psagot Investment House Ltd. ("Psagot") is based on Psagot's Schedule 13G filed with the SEC on February 16, 2016. Psagot reported shared voting power with regard to 1,763,850 shares and shared dispositive power with regard to 2,768,337 shares beneficially held by Psagot. Psagot reported that of the 2,768,337 shares reported (i)
1,004,489 shares are beneficially owned by portfolio accounts managed by Psagot Securities Ltd.
, (ii)
716,239 shares are beneficially owned by Psagot Exchange Traded Notes Ltd., (iii) 135,554 shares are beneficially owned by mutual funds managed by Psagot Mutual Funds Ltd. (of this amount, 10,300 shares may also be considered beneficially owned by Psagot Securities Ltd., but are not included in the shares beneficially owned by Psagot Securities Ltd., as indicated above)
(iv)
906,301 shares are beneficially owned by provident funds and pension funds managed by Psagot Provident Funds and Pension Ltd.
Psagot and (v) 5,756 shares are beneficially owned by managed savings managed by Psagot Insurance Company Ltd disclaims beneficial ownership of all of these shares. Psagot's address is Psagot Investment House Ltd. - 14 Ahad Ha’am Street, Tel Aviv 6514211, Israel.
|
|
(6)
|
The information provided herein is based, in part, on the Schedule 13D filed by FIMI with the SEC on February 17, 2015. Includes 7,314,118 shares beneficially owned by FIMI. Each of Gillon Beck and Ami Boehm is a partner of FIMI and has voting control of the shares held by FIMI. Accordingly, they may be deemed to share beneficial ownership of the shares held by FIMI. Each of Gillon Beck and Ami Boehm disclaim beneficial ownership of all such shares.
See also footnote 1 above.
|
|
(7)
|
The information provided for Itshak Sharon (Tshuva), Delek Group Ltd and The Phoenix Holding Ltd is based on their Schedule 13G/A filed with the SEC on June 2, 2015. The shares reported therein are beneficially owned by various direct or indirect, majority or wholly-owned subsidiaries of the Phoenix Holding Ltd. The Phoenix Holding Ltd. is a majority owned subsidiary of Delek Group Ltd. The majority of Delek Group Ltd’s outstanding share capital and voting rights are owned directly and indirectly by Itshak Sharon (Tshuva) through private companies wholly owned by him and the remainder is held by the public.
|
|
(8)
|
The information provided for The Vanguard Group ("Vanguard") is based on Vanguard's Schedule 13G/A filed with the SEC on February 11, 2016. Vanguard reported shared voting and dispositive power with regard to all of the 2,546,779 shares beneficially held by Vanguard. Vanguard's address is 100 Vanguard Blvd., Malvern, PA 19355.
|
|
(9)
|
Includes 30,000 shares of Common Stock issuable to Mr. Beck upon the exercise of options that are exercisable within 60 days of March 7, 2016. The options granted to Mr. Beck have exercise prices that range between $18.56 and $28.23 per share of Common Stock and expire at different periods between August 1, 2019 and November 5, 2021.
See also footnote 1 above.
|
|
(10)
|
Includes 22,500 shares of Common Stock issuable to Mr. Falk upon the exercise of options that are exercisable within 60 days of March 7, 2016. The options granted to Mr. Falk have exercise prices that range between $28.23 and $38.50 per share of Common Stock and expire at different periods between November 5, 2016 and November 5, 2021.
|
|
(11)
|
Includes 30,000 shares of Common Stock issuable to Mr. Boehm upon the exercise of options that are exercisable within 60 days of March 7, 2016. The options granted to Mr. Boehm have exercise prices that range between $18.56 and $28.23 per share of Common Stock and expire at different periods between August 1, 2019 and November 5, 2021.
See also footnote 1 above.
|
|
(12)
|
Includes (a) 2,000 shares of Common Stock purchased at market price and (b) 22,500 shares of Common Stock issuable to Mr. Clarke upon the exercise of options that are exercisable within 60 days of March 7, 2016. The options granted to Mr. Clarke have exercise prices that range between $26.70 and $38.50 per share of Common Stock and expire at different periods between November 5, 2016 and November 5, 2021.
|
|
(13)
|
Includes 15,000 shares of Common Stock issuable to Mr. Joyal upon the exercise of options that are exercisable within 60 days of March 7, 2016. The options granted to Mr. Joyal have exercise prices that range between $26.70 and $28.23 per share of Common Stock and expire at different periods between August 1, 2020 and November 5, 2021.
|
|
(14)
|
Includes 15,000 shares of Common Stock issuable to Mr. Granot upon the exercise of options that are exercisable within 60 days of March 7, 2016. The options granted to Mr. Granot have exercise prices that range between $26.70 and $28.23 per share of Common Stock and expire at different periods between August 1, 2020 and November 5, 2021.
|
|
(15)
|
Includes 99,375 shares of Common Stock issuable to Mr. Blachar upon the exercise of options that are exercisable within 60 days of March 7, 2016. The options granted to Mr. Blachar have an exercise price that range between $20.54 and $24.57 per share of Common Stock and expire between February 9, 2019 and April 2, 2019.
|
|
(16)
|
Includes 11,000 shares of Common Stock issuable to Mr. Krieger upon the exercise of options that are exercisable within 60 days of March 7, 2016. The options granted to Mr. Krieger have an exercise price of $25.65 per share of Common Stock and expire on April 2, 2019,
|
|
(17)
|
Includes 23,000 shares of Common Stock issuable to Mr. Hatzir upon the exercise of options that are exercisable within 60 days of March _, 2016. The options granted to Mr. Hatzir have exercise prices that range between $20.13 and 29.95 per share of Common Stock and expire at different periods between April 16, 2017 and April 2, 2019.
|
|
(18)
|
Includes 11,000 shares of Common Stock issuable to Mr. Wolf upon the exercise of options that are exercisable within 60 days of March 7, 2016. The options granted to Mr. Wolf have an exercise price of $20.13 per share of Common Stock and expire on April 2, 2019.
|
|
(19)
|
This number includes (a) 10,933,361 shares of Common Stock and (b) options (including SARs) to purchase 369,375 shares of Common Stock of the Company exercisable within 60 days of March 7, 2016, held directly (or deemed to be beneficially owned) by all of our directors and executive officers as a group. These options have exercise prices that range between $18.56 and $38.50 per share of Common Stock and expire at different periods between April 9, 2019 and November 5, 2021.
|
|
(20)
|
This number includes shares of Common Stock issuable to each of Ms. Barniv and Mr. Stern upon the exercise of options granted to them on January 5, 2016 that are exercisable within one year from the date of grant. The options granted to each of Ms. Barniv and Mr. Stern have an exercise price of $35.15 per share of Common Stock and expire on January 6, 2023.
|
|
(21)
|
Includes 75,000 shares of Common Stock issuable to Mr. Angel upon the exercise of options that are exercisable within 60 days of March 7, 2016. The options granted to Mr. Angel have an exercise price of $29.52 per share of Common Stock and expire on March 31, 2020.
|
|
|
1.
|
Annual salary, which is paid monthly, is intended to provide an annual income at a level consistent with individual contributions.
|
|
|
2.
|
Annual bonuses, which are paid annually for our executives, are intended to link our executive officers’ compensation to the Company’s overall performance, as well as, in most cases, their individual achievements.
|
|
|
3.
|
Equity awards are designed to promote long-term leadership and align the interests of our executives with those of our stockholders, while the vesting schedule assists us in retaining our executives in our employ. Equity awards typically begin to vest following two years from the date of grant, with 25% vesting on each of the second and third anniversaries of the date of grant and the remaining 50% on the fourth anniversary of the date of grant. All employees and consultants of the Company are eligible to receive equity awards pursuant to the Company's incentive compensation plan. The term of our equity awards typically ranges from six to ten years from the date of grant; as to our current executives, with the exception of two of our current named executive officers, there is no provision that provides for accelerated vesting upon a change in control; and there is no holding period for vested options.
|
|
Ravit Barniv, Chair
Dan Falk
Ami Boehm
David Granot
|
|
Name and Principal Position
|
Year
|
Salary ($)
|
Bonus ($)
(1)
|
Stock Awards ($)
|
Option Awards ($)
(2)
|
Non-Equity Incentive Plan Compensation ($)
(3)
|
Change in Pension Value and Nonqualified Deferred Compensation Earnings ($)
|
All Other Compensation ($)
|
Total ($)
|
|||||||||||||||||||||
|
Isaac Angel, Chief Executive Officer
(4)
|
2015
|
426,122 |
None
|
None
|
None
|
750,000 | 60,251 | 49,037 | (5) | 1,285,410 | ||||||||||||||||||||
|
2014
|
368,577 |
None
|
None
|
3,785,820 | 318,750 | 48,431 | 32,470 | 4,554,048 | ||||||||||||||||||||||
|
2013
|
N/A |
N/A
|
N/A | N/A | N/A | N/A | N/A | N/A | ||||||||||||||||||||||
|
Doron Blachar, Chief Financial Officer
|
2015
|
331,581 |
None
|
None
|
None
|
185,853 | 49,275 | 39,822 | (6) | 606,531 | ||||||||||||||||||||
|
2014
|
358,118 |
None
|
None
|
187,871 | 248,255 | 52,462 | 44,078 | 890,784 | ||||||||||||||||||||||
|
2013
|
263,470 |
None
|
None
|
564,000 | 62,566 | 38,469 | 25,287 | 953,792 | ||||||||||||||||||||||
|
Zvi Krieger, Executive Vice President of the Electricity Segment
|
2015
|
223,020 |
None
|
None
|
None
|
75,141 | 32,111 | 38,509 | (7) | 368,781 | ||||||||||||||||||||
|
2014
|
226,465 |
None
|
None
|
None
|
79,714 | 32,749 | 42,040 | 380,968 | ||||||||||||||||||||||
|
2013
|
211,640 |
None
|
None
|
337,500 | 78,208 | 28,924 | 44,000 | 700,272 | ||||||||||||||||||||||
|
Shimon Hatzir, Executive Vice President of Engineering
|
2015
|
200,354 |
None
|
None
|
None
|
90,902 | 28,891 | 37,275 | (8) | 357,422 | ||||||||||||||||||||
|
2014
|
217,337 |
None
|
None
|
None
|
45,287 | 31,479 | 33,759 | 327,862 | ||||||||||||||||||||||
|
2013
|
211,012 |
None
|
None
|
337,500 | 42,659 | 31,217 | 29,857 | 652,245 | ||||||||||||||||||||||
|
Bob Sullivan, Executive Vice President for Business Development Sales and Marketing
|
2015
|
231,800 |
None
|
None
|
None
|
86,500 | — | 30,172 | (9) | 348,472 | ||||||||||||||||||||
|
2014
|
184,391 |
None
|
None
|
None
|
41,000
|
— |
52,178
|
(10) |
277,569
|
|||||||||||||||||||||
|
2013
|
180,105 |
None
|
None
|
270,000 | 40,500 | — | 26,203 | 516,808 | ||||||||||||||||||||||
|
(1)
|
This column reflects the amount of any discretionary bonus (cash or non-cash) earned for the fiscal year. All other performance-based bonus awards are included in the ‘Non-Equity Incentive Plan Compensation’ column.
|
|
(2)
|
Represents the grant date fair value of all option awards in accordance with accounting guidance for stock compensation. The awards were SARs. Each NEO is entitled to receive shares of Common Stock equal to the amount by which the market value of the shares in respect of which the SAR is exercised exceeds the grant price set forth in the SAR, multiplied by the number of shares in respect of which the SAR is exercised.
The fair value of each grant of stock-based awards on the date of grant is estimated using the Black-Scholes valuation model and the assumptions noted in the following table.
|
|
Year Ended December 31,
|
||||||||||||
|
2015
|
2014
|
2013
|
||||||||||
|
Risk-free interest rates
|
1.4 | % | 1.7 | % | 0.8 | % | ||||||
|
Expected lives (in years)
|
4 | 5.1 | 4.6 | |||||||||
|
Dividend yield
|
0.7 | % | 0.9 | % | 0.71 | % | ||||||
|
Expected volatility
|
29.2 | % | 35.1 | % | 37.8 | % | ||||||
|
Forfeiture rate
|
0.0 | % | 0.0 | % | 5.6 | % | ||||||
|
(3)
|
This column excludes the amount of any discretionary bonus award earned for any year, including any such discretionary awards made under the Company’s Annual Management Incentive Plan adopted February 23, 2016, with effect from January 1, 2015 (the "Plan"). Consistent with the terms of the Plan, the amounts shown in this table reflect bonus amounts earned under the Plan for 2015 which are paid in 2016. This differs from the approach we used in the past in reporting items in this column. To present the numbers for prior years on a comparable basis, for the year in which earned rather than paid, we have included in this column amounts previously reported in our proxy statement for our 2015 annual meeting as follows: amounts shown in this column for 2013 were previously reported as amounts for 2014.
|
|
(4)
|
Isaac Angel commenced serving as an officer of the Company on April 1, 2014, and assumed the position of CEO as of July 1, 2014.
|
|
(5)
|
Includes payments of car-related expenses in the amount of $20,467; Israel National Insurance in the amount of $9,026; U.S. Social Security in the amount of $9,533; health insurance in the amount of $212; convalescence pay in the amount of $2,914; Education Fund in the amount of $3,638 and perquisites amounting to $3,247.
|
|
(6)
|
Includes payments of car-related expenses in the amount of $21,023; Israel National Insurance in the amount of $9,026; health insurance in the amount of $47; convalescence pay in the amount of $1,665; Education Fund in the amount of $3,638; and perquisites amounting to $4,423.
|
|
(7
|
Includes payments of car-related expenses in the amount of $12,873; Israel National Insurance in the amount of $9,026; health insurance in the amount of $47; convalescence pay in the amount of $1,665; Education Fund in the amount of $3,638; vacation redemption of $8,397; and perquisites amounting to $2,863.
|
|
(8)
|
Includes payments of car-related expenses in the amount of $12,873; Israel National Insurance in the amount of $9,026; convalescence pay in the amount of $1,665; Education Fund in the amount of $3,638; vacation redemption of $6,559; and perquisites amounting to $3,514.
|
|
(9)
|
Includes payments of social security in the amount of $9,290; health insurance in the amount of $17,382 and 401(k) plan contributions amounting to $3,500.
|
|
(10)
|
Includes a $25,000 relocation allowance
|
|
●
|
Salary: Annual gross salary of NIS 1,620,000 (equal to approximately $416,000 based on the representative exchange rate set by the Bank of Israel on March 4, 2016), which is linked to the Israeli consumer price index.
|
|
●
|
Annual Performance Bonus: If the Company's annual consolidated net income ("Annual Profits") is above $20 million, Mr. Angel will be entitled to receive an annual bonus (the "Annual Bonus") equal to (a) 0.75% of Annual Profits of up to $50 million (inclusive), and (b) 1.00% of the portion of the Annual Profits, if any, that is above $50 million; provided that, in any event, the Annual Bonus shall not exceed $750,000.
|
|
●
|
Initial Option Grant: Stock options granted on April 1, 2014
to purchase 100,000 shares of common stock at an exercise price equal to $29.52, the closing price of the common stock on the date of grant. The options were granted under our 2012 Incentive Compensation Plan and vest in one installment on the seventh (7
th
) anniversary of the date of grant. These options expire seven and a half (7.5) years following the grant date.
|
|
●
|
Second Option Grant: Stock options granted on April 1, 2014
to purchase 300,000 shares of common stock at an exercise price equal to $29.52, the closing price of the common stock on the date of grant. These options were granted under our 2012 Incentive Compensation Plan and vest in four equal installments, commencing with the second (2
nd
) anniversary of the date of grant. These options expire six (6) years following the grant date.
|
|
●
|
Termination: Each of the Company and Mr. Angel may terminate the employment with the Company, for any reason, by providing six (6) months of prior notice of such termination (the "Notice Period"). Other than in the case of termination of employment with the Company for "cause", Mr. Angel will be entitled to continue to receive his compensation during the Notice Period.
|
|
●
|
Termination in connection with a Change of Control: In the event that Mr. Angel's employment is terminated by the Company without cause, or he resigns for a "good reason", within two (2) months before, or twelve (12) months following, the consummation of a "change of control" (as defined in the Employment Agreement), Mr. Angel is entitled to the following: (i) the Notice Period (and consequently, the period during which compensation is payable to Mr. Angel) will be extended from six (6) months to twelve (12) months; and (ii) all the stock options described above are accelerated and will become fully vested and exercisable.
|
|
Option Awards
|
|||||||||||||
|
Name
|
Number of Securities
Underlying Unexercised Options (#) Exercisable
|
Number of Securities
Underlying Unexercised Options (#) Unexercisable
|
Option
Exercise Price ($)
|
Option Expiration Date
|
|||||||||
|
Isaac Angel
|
None
|
100,000 | (1) | 29.52 |
September 30,2021
|
||||||||
|
None
|
300,000 | (2) | 29.52 |
March 31, 2020
|
|||||||||
|
Doron Blachar
|
50,000 | 50,000 | (3) | 20.54 |
April 2, 2019
|
||||||||
| 16,250 | 16,250 | (4) | 24.57 |
February 9, 2019
|
|||||||||
|
Zvi Krieger
|
15,000 |
None
|
34.13 |
April 7, 2016
|
|||||||||
| 12,000 | — | 25.65 |
March 31, 2018
|
||||||||||
|
None
|
11,000 | (6) | 20.13 |
April 2, 2019
|
|||||||||
| 12,500 | 37,500 | (7) | 23.34 |
June 4, 2019
|
|||||||||
|
Shimon Hatzir
|
9,000 |
None
|
34.13 |
April 7, 2016
|
|||||||||
| 24,000 |
None
|
29.95 |
April 16, 2017
|
||||||||||
| — | 11,000 | (6) | 20.13 |
April 2, 2019
|
|||||||||
| 12,500 | 37,500 | (7) | 23.34 |
June 4, 2019
|
|||||||||
|
Nir Wolf
|
3,500 |
None
|
34.13 |
April 7, 2016
|
|||||||||
|
None
|
11,000 | (6) | 20.13 |
April 2, 2019
|
|||||||||
|
None
|
37,500 | (7) | 23.34 |
June 4, 2019
|
|||||||||
|
|
(1)
|
These are stock options, which will become fully vested seven years following the date of the grant. This vesting schedule is subject to acceleration in certain circumstances upon a change of control, as described above under "Employment Agreements – Isaac Angel".
|
|
|
(2)
|
These are stock options which vest in four equal installments, commencing March 31, 2016. The options expire six years from the date of grant. This vesting schedule is subject to acceleration in certain circumstances upon a change of control, as described above under "Employment Agreements – Isaac Angel".
|
|
|
(3)
|
These are stock options which began to vest one year after the April 2013 grant date, with 25% of the stock options vesting on each of the first, second, third, and fourth anniversaries of the grant date. The stock options will become completely exercisable in April 2017.
|
|
|
(4)
|
These are stock options which began to vest one year after the February 2014 grant date, with 50% of the stock options vesting on the first anniversary of the grant date and 25% of the stock options vesting on each of the second and third anniversaries of the grant date. The stock options become fully exercisable in February 2017.
|
|
|
(5)
|
These are SARs which began to vest two years after the March 2011 grant date, with 25% of the SARs vesting on each of the second and third anniversaries of the grant date, and the remaining 50% on the fourth anniversary of the grant date. The SARs will become completely exercisable in March 2015. Each NEO is entitled to receive shares of Common Stock equal to the amount by which the market value of the shares in respect of which the SAR is exercised exceeds the grant price set forth in the SAR, multiplied by the number of shares in respect of which the SAR is exercised.
|
|
|
(6)
|
These are SARs which began to vest two years after the April 2012 grant date, with 25% of the SARs vesting on each of the second and third anniversaries of the grant date, and the remaining 50% on the fourth anniversary of the grant date. The SARs will become completely exercisable in April 2016. Each NEO is entitled to receive shares of Common Stock equal to the amount by which the market value of the shares in respect of which the SAR is exercised exceeds the grant price set forth in the SAR, multiplied by the number of shares in respect of which the SAR is exercised.
|
|
|
(7)
|
These are SARs which began to vest two years after the June 2013 grant date, with 25% of the SARs vesting on each of the second and third anniversaries of the grant date, and the remaining 50% on the fourth anniversary of the grant date. The SARs will become completely exercisable in June 2017. Each NEO is entitled to receive shares of Common Stock equal to the amount by which the market value of the shares in respect of which the SAR is exercised exceeds the grant price set forth in the SAR, multiplied by the number of shares in respect of which the SAR is exercised.
|
|
Name
|
Number of Shares Acquired on Exercise (#)
|
Value Realized on Exercise ($)
|
||||||
|
Zvi Krieger
|
17,581 | 627,242.89 | ||||||
|
Nir Wolf
|
22,756 | 855,917.36 | ||||||
|
Shimon Hatzir
|
16,544 | 608,627.14 | ||||||
|
Name
|
Termination without Cause ($)
|
Change in Control ($)
|
||||||
|
Isaac Angel
|
388,262 | 776,524 | ||||||
|
Doron Blachar
|
215,847 | 215,847 | ||||||
|
Zvi Krieger
|
354,868 | 354,868 | ||||||
|
Shimon Hatzir
|
536,841 | 536,841 | ||||||
|
Nir Wolf
|
464,938 | 464,938 | ||||||
|
Name
|
Fee Earned or Paid in Cash ($)
|
Options Awards($)
(1)(2)
|
Total ($)
|
|||||||||
|
Gillon Beck
|
62,000 | 65,120 | 127,120 | |||||||||
|
Yoram Bronicki
(3)
|
885,317 |
None
|
885,317 | |||||||||
|
Ami Boehm
|
67,500 | 65,210 | 132,620 | |||||||||
|
Dan Falk
|
82,000 | 65,210 | 147,120 | |||||||||
|
Robert F. Clarke
|
66,000 | 65,210 | 131,120 | |||||||||
|
David Granot
|
69,500 | 65,210 | 134,620 | |||||||||
|
Robert E. Joyal
|
68,500 | 65,210 | 133,620 | |||||||||
|
Yehudit Bronicki
|
61,500 |
None
|
61,500 | |||||||||
|
Ravit Barniv
|
5,000 |
None
|
5,000 | |||||||||
|
Stanley Stern
|
5,000 |
None
|
5,000 | |||||||||
|
|
(1)
|
Represents the grant date fair value in accordance with accounting guidance for stock compensation. For a discussion of the assumptions used in reaching this valuation, see note 1 to the Summary Compensation Table above.
|
|
|
(2)
|
At fiscal year-end, each non-management director held the following aggregate number of option awards: (i) Mr. Beck held options to purchase 37,500 shares; (ii) Mr. Boehm held options to purchase 37,500 shares; (iii) Mr. Granot held options to purchase 22,500 shares; (iv) Mr. Joyal held options to purchase 22,500 shares; (v) Mr. Falk held options to purchase 30,000 shares; and (vi) Mr. Clarke held options to purchase 30,000 shares.
|
|
|
(3)
|
Includes an annual salary of $168,000, annual bonus of $640,000 and other related benefits of $77,317 payable in accordance with the terms of his employment agreement
|
|
|
·
|
Base annual retainer of $40,000 as fees related to their service on our Board.
|
|
|
·
|
Board meeting fees of $2,500 per day for each in-person meeting attended; $500 per day for each telephonic meeting attended; and $1,000 per day for telephonic participation in an in-person meeting.
|
|
|
·
|
Committee meeting fees of $1,500 per day for each in-person meeting attended and $500 per day for each telephonic meeting attended.
|
|
|
·
|
Any non-employee director who also serves as Chair of the Audit Committee receives an annual retainer of $7,500. Chairs of our other committees do not receive an annual retainer.
|
|
|
·
|
We promptly reimburse all directors for transportation and lodging expenses actually incurred to attend meetings of our Board or committees.
|
|
|
o
|
voting agreements with the then principal shareholders of Ormat Industries, FIMI and Bronicki, which, following the share exchange, beneficially owned approximately 15.06% and 8.84% of our outstanding shares, respectively. Under these voting agreements, FIMI and Bronicki agreed, among other things, to comply in all respects with the Israeli Tax Ruling applicable to the Ormat Industries shareholders.
|
|
|
o
|
voting neutralization agreements with FIMI and Bronicki, whereby FIMI and Bronicki agreed, among other things, to certain restrictions on their shares of our common stock. Among other things, these voting neutralization agreements:
|
|
§
|
require these shareholders to vote all voting securities owned by FIMI and Bronicki and their respective affiliates in excess of 16% and 9%, respectively, of the combined voting power of our shares in proportion to votes cast by the other holders of our voting securities at any time any action is to be taken by our stockholders;
|
|
§
|
prohibit the acquisition of our voting securities by FIMI and Bronicki and their respective affiliates if after giving effect to any such acquisition FIMI and Bronicki and their respective affiliates would beneficially own voting securities representing in the aggregate more than 20% and 12%, respectively, of the combined voting power of our shares;
|
|
§
|
prohibit, prior to January 1, 2017, the sale of more than 10% of our voting securities owned in the aggregate by FIMI and Bronicki;
|
|
§
|
allow, following January 1, 2017, the sale of our voting securities owned by FIMI and Bronicki only if they are not acting in concert to sell or, if they are, only with 20 days’ prior written notice to us, subject to certain exceptions for public sales and mergers and acquisitions transactions; and
|
|
§
|
prohibit FIMI and Bronicki from renewing their shareholder rights agreement beyond its expiration date, May 22, 2017.
|
|
|
o
|
a registration rights agreement whereby FIMI and Bronicki may, subject to certain limitations, require us to prepare and file with the SEC a registration statement to register a public offering of the shares of our common stock held by them, on customary terms and conditions set forth in the agreement.
|
|
·
|
voting and transfers of the shares of our common stock held by Bronicki Investments and FIMI followin
g
the share exchange (including a right of first offer, "tag-along" right, a "bring-along" right and, by way of an amendment to the SPA, a call option right to FIMI);
|
|
·
|
the composition of our Board as further detailed below;
|
|
·
|
agreements concerning various corporate policies and governance matters relating to us and our subsidiaries, to the extent subject to a vote of our stockholders (namely, that unless otherwise agreed and as long as the parties hold a certain minimum percentage of our share capital, the parties will vote against liquidation or entrance into any bankruptcy or similar proceeding by us (or a material subsidiary thereof, if under applicable law it is required to be brought to the parties’ approval), a material change in our field of operations (or a material subsidiary thereof, if under applicable law it is required to be brought to the parties’ approval), and/or amendment of our Articles of Association with respect to our staggered Board); and
|
|
·
|
compliance with the Israeli Tax Ruling, including the internal allocation between Bronicki Investments and FIMI of the amount of shares they are permitted to sell under the Israeli Tax Ruling.
|
|
·
|
subject to any applicable law and fiduciary duties, use their reasonable efforts to cause the number of designees of Bronicki Investments and FIMI to be elected or appointed to our Board as detailed below. Specifically, Bronicki Investments and FIMI agreed that they will each have the right to designate four members to our Board, subject to staged adjustments if either Bronicki Investments or FIMI or both cease to own specified minimum numbers of our shares within various ranges specified in the SHA, including minimum shareholdings below which such shareholder loses the right of directors’ designation. Currently, the number of directors that Bronicki Investments and FIMI may designate is three and five, respectively.
|
|
Number of
Securities to be
Issued Upon
Exercise of
Outstanding
Options, Warrants
and Rights
|
Weighted Average
Exercise Price of
Outstanding Options,
Warrants and Rights
|
Number of Securities
Remaining Available for
Future Issuance Under
Equity Compensation Plans
|
||||||||||
|
Equity Compensation plans approved
by security holders
|
2,437,560 | * | $ | 25.38 | 2,167,525 | † | ||||||
|
Equity Compensation plans not approved by security holders
|
-- | N/A | -- | |||||||||
|
Total
|
2,437,560 | * | $ | 25.38 | 2,167,525 | † | ||||||
|
*
|
Stock options issued pursuant to our 2004 Incentive Compensation Plan, as amended, and our 2012 Incentive Compensation Plan, as amended, and our Registration Statement on Form S-8 covering 1,250,000 shares filed with the SEC on November 9, 2005, our Registration Statement on Form S-8 covering 2,500,000 shares filed with the SEC on June 4, 2007, and our Registration Statement on Form S-8 covering 4,000,000 shares filed with the SEC on May 18, 2012.
|
|
†
|
On May 8, 2012, at the Company’s 2012 annual meeting of shareholders, the Company’s shareholders approved the Ormat Technologies, Inc. 2012 Incentive Compensation Plan, which the Board had adopted on March 20, 2012. No further awards will be granted under the 2004 Incentive Compensation Plan, though there are still unexercised options outstanding under the 2004 Incentive Compensation Plan. On May 18, 2012, the Company filed a post-effective Amendment No. 1 to Form S-8 whereby the Company removed from registration 51,149 unissued shares that had remained available for grant under the 2004 Incentive Compensation Plan, as amended.
|
|
|
Year Ended December 31,
|
|
3-Year
Average
|
|||||||||||||
|
|
2015
|
|
2014
|
|
2013
|
|
||||||||||
|
Options and SARs granted
|
|
None
|
485,000
|
1,303,100
|
|
|
||||||||||
|
Weighted average shares of common stock outstanding
|
|
48,562
|
45,859
|
45,475
|
|
|
||||||||||
|
Burn rate
|
|
|
|
1.06%
|
|
|
2.87%
|
|
|
1.28
|
%
|
|||||
|
2015
|
2014
|
|||||||
|
Audit Fees
(1)
|
$ | 2,058,304 | $ | 2,075,600 | ||||
|
Audit-Related Fees
(2)
|
$ | 491,871 | $ | 16,200 | ||||
|
Tax Fees
(3)
|
$ | 331,515 | $ | 382,395 | ||||
|
All Other Fees
(4)
|
$ | 3,870 | $ | 36,100 | ||||
|
Total
:
|
$ | 2,885,560 | $ | 2,510,295 | ||||
|
|
(1)
|
Audit Fees represent the aggregate fees billed for the audits of the annual financial statements and the Company’s internal control over financial reporting; for review of the financial statements included in the Company’s Form 10-Q filings; for the audits and reviews of certain of our subsidiaries; and for services that are normally provided by the independent registered public accounting firm in connection with statutory and regulatory filings.
|
|
|
(2)
|
Audit-Related Fees represent the aggregate fees billed for services related to the performance of the audit or review of our financial statements and that are not reported under paragraph (1) above, due diligence related to mergers and acquisitions and consulting on financial accounting/reporting standards .
|
|
|
(3)
|
Tax Fees represent the aggregate fees billed for international tax compliance, tax advice, and tax planning services.
|
|
|
(4)
|
All Other Fees represent annual software license fees.
|
|
By order of the Board,
/s/ Isaac Angel
Isaac Angel
Chief Executive Officer
|
|
1.
|
Election of Directors.
|
| (1) Gillon Beck |
FOR
o
|
AGAINST
o
|
ABSTAIN
o
|
| (2) Dan Falk |
FOR
o
|
AGAINST
o
|
ABSTAIN
o
|
|
2.
|
To ratify the selection of PricewaterhouseCoopers LLP as independent auditors of the Company for its fiscal year ending December 31, 2016.
|
|
FOR
o
|
AGAINST
o
|
ABSTAIN
o
|
|
3.
|
In their discretion, the proxies are authorized to vote upon such other business as may properly come before the meeting.
|
|
Note:
|
Please sign exactly as your name or names appear on this Proxy. When shares are held jointly, each holder should sign. When signing as executor, administrator, attorney, trustee or guardian, please give full title as such. If the signer is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. If signer is a partnership, please sign in partnership name by authorized person.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|